Search results
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 1 day agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 9 hours agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Kristin Chenoweth Says 'It's Wonderful to Find Your Person' After Marrying Josh Bryant: 'I Waited...
OK! Magazine· 3 days agoShe finally got that ring!
AbbVie Completes Acquisition of Landos Biopharma
Valley City Times Record· 1 day agoWith the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like ...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 4 days agoWall Street is feeling pretty good about AbbVie's (NYSE: ABBV) performance in 2024 so far. Louise...
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...
Benzinga via AOL· 5 hours agoU.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...
AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands of...
JD Supra· 2 days agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the ...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 2 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on AbbVie ABBV . And retail traders should know. We noticed this today when the positions ...
2 Billion More Reasons to Buy AbbVie Stock
Motley Fool via Yahoo Finance· 2 days agoThere are plenty of reasons to buy a leading biopharma business like AbbVie (NYSE: ABBV), and investors just got at least a few more. Thanks to a large...
AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald
ETF DAILY NEWS· 6 days agoCantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald ...